This topic contains a solution. Click here to go to the answer

Author Question: Which of the following details about the sampling plan could the researcher reasonably exclude from ... (Read 17 times)

penza

  • Hero Member
  • *****
  • Posts: 1,022
Which of the following details about the sampling plan could the researcher reasonably exclude from the body of the report?
 a. How the population was defined and limited
  b. How the list of sampling units was generated
  c. What bias may have been introduced by overcoming difficulties in contacting designated sample elements
  d. Why the size of sample was chosen
  e. Calculations used to determine the sample size

Question 2

A true statement about consumer practices related to the security of their data is:
 a. most users don't use security software.
  b. most users are not sure they are protected from malware.
  c. most users don't feel safe using online banking.
  d. All of these are correct.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

chem1s3

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

e

Answer to Question 2

b




penza

  • Member
  • Posts: 1,022
Reply 2 on: Jun 28, 2018
Wow, this really help


Alyson.hiatt@yahoo.com

  • Member
  • Posts: 354
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

The FDA recognizes 118 routes of administration.

For a complete list of videos, visit our video library